Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Joshua Riggs — FY2025 total compensation $2,594,786

Joshua Riggs is President and Chief Executive Officer of Insight Molecular Diagnostics Inc. (IMDX). The company reported total compensation of $2,594,786 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$472,293
Bonus$184,675
Stock awards$599,999
Option awards$1,332,000
Non-equity incentive plan$0
Pension and non-qualified deferred compensation$0
All other compensation$5,819
Total$2,594,786

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Insight Molecular Diagnostics Inc. filed April 30, 2026, accession 0001493152-26-020502.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$472,293$184,675$599,999$1,332,000$0$0$5,819$2,594,786
FY2024President and Chief Executive Officer$385,018$166,400$0$209,709$24,950$0$0$786,077

Totals as disclosed in each year's own compensation disclosure for Insight Molecular Diagnostics Inc..

04

The other named executive officers of Insight Molecular Diagnostics Inc.

Named executive officerRoleFY2025 total
Joshua Riggs this pagePresident and Chief Executive Officer$2,594,786
Andrea JamesChief Financial Officer$1,679,126
James LiuVP of Accounting, Controller, Treasurer & Principal Accounting Officer$454,990

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Insight Molecular Diagnostics Inc. compensation brief.

05

The company page

Joshua Riggs's compensation sits inside Insight Molecular Diagnostics Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Insight Molecular Diagnostics Inc. (IMDX) compensation brief